Inside Nephrology: A Weekly Review
Nefrologia
Kidney Transplantation and Nephrology Updates
This week's nephrology update covers kidney transplantation techniques, new ADPKD guidelines, advances in renal-cell carcinoma treatment, and important safety findings in autoimmune disease management.
Bibliography
1. Normothermic versus hypothermic machine perfusion in kidney transplantation: A randomized controlled trial.
Authors: Slagter JS, Bouari S, Rijkse E, et al.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2026 May
PMID: 41453736
DOI: 10.1016/j.ajt.2025.12.021
2. Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Authors: de Bono J, Mateo J, Fizazi K, et al.
Journal: The New England journal of medicine, 2020 May 28
PMID: 32343890
DOI: 10.1056/NEJMoa1911440
3. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline.
Authors: Manes G, Paspatis G, Aabakken L, et al.
Journal: Endoscopy, 2019 May
PMID: 30943551
DOI: 10.1055/a-0862-0346
4. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
Authors: Vincenti F, Charpentier B, Vanrenterghem Y, et al.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010 Mar
PMID: 20415897
DOI: 10.1111/j.1600-6143.2009.03005.x
5. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary.
Authors: Torres VE, Ahn C, Barten TRM, et al.
Journal: Kidney international, 2025 Feb
PMID: 39848746
DOI: 10.1016/j.kint.2024.07.010
6. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Authors: Motzer RJ, Tannir NM, McDermott DF, et al.
Journal: The New England journal of medicine, 2018 Apr 5
PMID: 29562145
DOI: 10.1056/NEJMoa1712126
7. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes.
Authors: Tonelli M, Wiebe N, Knoll G, et al.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2011 Oct
PMID: 21883901
DOI: 10.1111/j.1600-6143.2011.03686.x
8. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
Authors: Vincenti F, Charpentier B, Vanrenterghem Y, et al.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010 Mar
PMID: 20415897
DOI: 10.1111/j.1600-6143.2009.03005.x
9. Bibliometric analysis of SGLT2 inhibitor treatment for diabetic kidney disease.
Authors: Hu D, Chen L, Mai R, et al.
Journal: Renal failure, 2026 Dec
PMID: 42167310
DOI: 10.1080/0886022X.2026.2667611
10. Obinutuzumab-induced acute thrombocytopenia and leukopenia in ANCA-associated glomerulonephritis: case report and literature review.
Authors: Jin Y, Huang Y, He X
Journal: Frontiers in immunology, 2026
PMID: 42164499
DOI: 10.3389/fimmu.2026.1845580
Authors: Slagter JS, Bouari S, Rijkse E, et al.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2026 May
PMID: 41453736
DOI: 10.1016/j.ajt.2025.12.021
2. Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Authors: de Bono J, Mateo J, Fizazi K, et al.
Journal: The New England journal of medicine, 2020 May 28
PMID: 32343890
DOI: 10.1056/NEJMoa1911440
3. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline.
Authors: Manes G, Paspatis G, Aabakken L, et al.
Journal: Endoscopy, 2019 May
PMID: 30943551
DOI: 10.1055/a-0862-0346
4. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
Authors: Vincenti F, Charpentier B, Vanrenterghem Y, et al.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010 Mar
PMID: 20415897
DOI: 10.1111/j.1600-6143.2009.03005.x
5. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary.
Authors: Torres VE, Ahn C, Barten TRM, et al.
Journal: Kidney international, 2025 Feb
PMID: 39848746
DOI: 10.1016/j.kint.2024.07.010
6. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Authors: Motzer RJ, Tannir NM, McDermott DF, et al.
Journal: The New England journal of medicine, 2018 Apr 5
PMID: 29562145
DOI: 10.1056/NEJMoa1712126
7. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes.
Authors: Tonelli M, Wiebe N, Knoll G, et al.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2011 Oct
PMID: 21883901
DOI: 10.1111/j.1600-6143.2011.03686.x
8. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
Authors: Vincenti F, Charpentier B, Vanrenterghem Y, et al.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010 Mar
PMID: 20415897
DOI: 10.1111/j.1600-6143.2009.03005.x
9. Bibliometric analysis of SGLT2 inhibitor treatment for diabetic kidney disease.
Authors: Hu D, Chen L, Mai R, et al.
Journal: Renal failure, 2026 Dec
PMID: 42167310
DOI: 10.1080/0886022X.2026.2667611
10. Obinutuzumab-induced acute thrombocytopenia and leukopenia in ANCA-associated glomerulonephritis: case report and literature review.
Authors: Jin Y, Huang Y, He X
Journal: Frontiers in immunology, 2026
PMID: 42164499
DOI: 10.3389/fimmu.2026.1845580
